Brighthouse Financial (BHF, Life & Health Insurance) Stock Valuation & Fair Value Fairly valued
Brighthouse Financial (BHF, Life & Health Insurance) trades at a blended P/E of 2.3, about 46% below its historical normal valuation, with a forward growth estimate of -0.9%. Analysts' one-year estimates have been hit 13% of the time. Priced at its historical normal P/E of 4.3 on the same blended earnings, the 2026-09-18 close of $49.95 corresponds to about $92.20 a share. This is a valuation reference, not a price target.
No quality score is published for this company, which is normal for insurers, banks and REITs. This rating reflects valuation, forecast return and analyst accuracy only. Ratings that cite business quality require one.
The Street vs SeerForecast
Wall Street's mean price target for BHF is $65.00 across 6 analysts, 25.0% above the current price. Our SeerForecast read of the same stock, formed without analyst targets: fairly valued. When the two disagree, start your digging there.
Valuation flags
- Negative growth forecast
Verdict history
tickerseer's rating has been fairly valued since 2026-08-07.
Not every point was recorded live. Points marked recalculated apply today's valuation rules to the metrics tickerseer archived that week.
Selected weeks: the first, the latest, and the cheapest and dearest.
Frequently asked questions
Is Brighthouse Financial stock overvalued?
At a blended P/E of 2.3 versus its historical normal P/E of 4.3, Brighthouse Financial trades about 46% below its typical valuation. tickerseer currently rates it fairly valued.
What is Brighthouse Financial's fair value and PEG?
Brighthouse Financial trades at a blended P/E of 2.3 against a historical normal P/E of 4.3, a forward growth estimate of -0.9%. Priced at its historical normal P/E of 4.3 on the same blended earnings, the 2026-09-18 close of $49.95 corresponds to about $92.20 a share. This is a valuation reference, not a price target.
Has tickerseer's rating of Brighthouse Financial changed?
tickerseer's rating has been fairly valued since 2026-08-07.
What is the analyst price target for Brighthouse Financial?
The mean Wall Street price target for Brighthouse Financial is $65.00 across 6 analysts, 25.0% above the current price. tickerseer's SeerForecast verdict is formed independently of analyst targets.
Industry: Life & Health Insurance. Create a free account to see the full analysis: the SeerAI score, valuation history, and the AI research note. Options setups and metric history are part of the paid plans.
Get the free weekly earnings preview
One email each Monday with the week's named earnings setups, the reasoning, and what settled last week. Strikes and sizing stay in Premium.
It's free, and you can unsubscribe any time. We also send a short product update once a month. Educational content, not investment advice.